Skip to content

Once again research finds health benefits from consumption of olive oil. A recent large study found that consuming more than 1/2 tablespoon of olive oil per day lowered the risk of death from heart disease, cancer, neurogenerative disease, and respiratory disease.

The Harvard T.H. Chan School of Public Health researchers also found that increasing intake of olive oil in the diet (replacing margarine, butter, mayonnaise, and dairy fat with 2 1/4 teaspoons or 3/4 tablespoons olive oil) lowers risk of early death in general. The study participants were followed for 28 years, and diet was assessed every 4 years.

Earlier studies found that the best kind of olive oil to consume is extra virgin olive oil (EVOO). Extra virgin olive oil is considered anti-inflammatory, and contains oleocanthal, which has anticancer effects. Health benefits are both if eaten as is (e.g., dunk bread, in salad dressings) or cooked (e.g. roast vegetables, in sauces, cooking foods) - and this result was also found in this recent study.

From Science Daily: Higher olive oil intake associated with lower risk of CVD mortality

Consuming more than 7 grams (>1/2 tablespoon) of olive oil per day is associated with lower risk of cardiovascular disease mortality, cancer mortality, neurodegenerative disease mortality and respiratory disease mortality, according to a study publishing today in the Journal of the American College of Cardiology. The study found that replacing about 10 grams/day of margarine, butter, mayonnaise and dairy fat with the equivalent amount of olive oil is associated with lower risk of mortality as well.  ...continue reading "Olive Oil Lowers the Risk of Death From Several Diseases"

Oil palms Credit: Wikipedia

An interesting and potentially important cancer study was just published, but will the results hold up in humans? Researchers found that a diet rich in palm oil, which contains palmitic acid, promoted the spread (metastasizing) of two cancers - oral carcinomas and melanoma skin cancer. In mice.

Palm oil is very commonly used in foods. However, the international team of researchers did not find this occurring with fatty acids that are found in olive oil or flaxseeds. (They contain oleic acid or linoleic acid, which are omega-9 and omega-6 fats.)

What does this mean? In this study, dietary palm oil promoted the spread of existing cancers in mice. If you want to be extra cautious, especially if you already have cancer, avoid palm oil and perhaps instead use olive oil. Professor Benitah, one of the researchers said:

"I think it is too early to determine which type of diet could be consumed by patients with metastatic cancer that would slow down the metastatic process. That said, based on our results one would think that a diet poor in palmitic acid could be effective in slowing down the metastatic process, but much more work is needed to determine this."

Of course further studies are needed in humans. But... it is important to note that extra virgin olive oil is viewed as anti-inflammatory and linked to a lower incidence of some cancers, including breast cancer.

From Medical Xpress: Researchers discover link between dietary fat and the spread of cancer

The study, published in the journal Nature and part-funded by the UK charity Worldwide Cancer Research, uncovers how palmitic acid alters the cancer genome, increasing the likelihood the cancer will spread. The researchers have started developing therapies that interrupt this process and say a clinical trial could start in the next couple of years.  ...continue reading "Possible Link Between Palm Oil and Cancer Spread"

Once again the Mediterranean diet is linked to health benefits - this time a 40% lower incidence of certain types of breast cancer in postmenopausal women. Following a Mediterranean style diet has been linked in earlier studies to various health benefits, such as lower rates of heart disease, lower rates of early death, and certain cancers.

A strength of this study is that so many (62,573) Dutch postmenopausal women were followed for a long time (about 20 years). Their diet was analyzed, especially how closely it matched the Mediterranean diet or not. Since alcohol is a risk factor for breast cancer, and dose-related - it was not included as part of the Mediterranean diet in this study. The study found that following a Mediterranean diet with higher consumption of nuts, fruits, vegetables, and whole grains, appeared to be protective against certain breast cancers - it was associated with a reduced risk of estrogen receptor–negative (ER-) breast cancers. Unfortunately the researchers did not look at olive oil use in this study, because when it started in 1986, it was not typically used in the Netherlands. However, another good study found extra virgin olive oil to be a protective part (against breast cancer) of the Mediterranean diet. From Medscape:

Mediterranean Diet Cuts Some Breast Cancer Risk by 40%

Closely following a Mediterranean diet in everyday life may significantly reduce the risk for types of breast cancer that are associated with poorer prognoses in postmenopausal women, new research indicates. The traditional Mediterranean diet is characterized by a high intake of plant proteins, whole grains, fish, and monounsaturated fat, as well as moderate alcohol intake and low intake of refined grains, red meat, and sweets, say the study authors, led by Piet A. van den Brandt, PhD, an epidemiologist at the Maastricht University Medical Center in the Netherlands.

The new findings come from 62,573 Dutch women aged 55 to 69 years who provided information on dietary and lifestyle habits in 1986 and have since been followed for more than 20 years....The investigators found that women who most closely adhered to a Mediterranean diet had a 40% reduced risk for estrogen receptor–negative (ER-) breast cancer compared to women who adhered to the diet the least. They found a 39% reduced risk for progesterone receptor–negative (PR-)/ER- disease when comparing these same high- and low-adherence groups. Notably, in these results, the definition of the diet excluded alcohol intake, because the consumption of alcohol is a known risk factor for breast cancer....The authors also report that there were no significant associations with the diet and the risk of ER+ disease or total breast cancer.

Dr van den Brandt also explained that older women, who were the subjects of the new study, are more likely to derive benefit than younger women. "Generally speaking, postmenopausal breast cancer seems somewhat more influenced by environmental factors, such as lifestyle and diet, than premenopausal breast cancer, where genetic factors seem to play a more prominent role," he told Medscape Medical News.

Dr Toledo was the senior author of the only large, randomized trial to date in which postmenopausal women were assigned to a dietary intervention to promote their adherence to the traditional Mediterranean diet (JAMA Intern Med. 2015;175:1752–60). The study found that women with a higher adherence to the diet (supplemented with extra-virgin olive oil) showed a substantial reduction of their risk for breast cancer compared to a control group, as reported by Medscape Medical News.

The following studies reinforce the advice that people should eat a variety of fruits and vegetables, as well as olive oil (part of the Mediterranean diet).

Studies find that consumption of fruits, vegetables, herbs, and extra virgin olive oil have various health benefits, and the following studies, even though not done with humans, suggest some reasons for their health benefits.

Luteolin appears to have anti-tumor effects, and so may reduce cancer risk. Dietary sources of luteolin include celery, broccoli, green pepper, parsley, thyme, dandelion, perilla, chamomile tea, carrots, olive oil, peppermint, rosemary, navel oranges, and oregano. Extra-virgin olive oil contains the ingredient oleocanthal, which appears to kill a variety of human cancer cells without harming healthy cells.

From Science Daily: Natural compound could reduce breast cancer risk in some women

The odds of women being diagnosed with breast cancer increase in postmenopausal women who have taken a combined estrogen and progestin hormone replacement therapy; these women also have an increased risk of developing progestin-accelerated breast tumors. Now, researchers have found that luteolin, a natural compound found in herbs such as thyme and parsley as well as vegetables such as celery and broccoli, could reduce the cancer risk for women who have taken hormone replacement therapy.

 "Nevertheless, research has proven that a higher incidence of breast cancer tumors can occur in women receiving therapies that involve a combination of the natural component estrogen and the synthetic progestin. Most older women normally have benign lesions in breast tissue," Hyder said. "These lesions typically don't form tumors until they receive the 'trigger'-- in this case, progestin--that attracts blood vessels to cells essentially feeding the lesions causing them to expand." His newest study shows that when the supplement luteolin is administered to human breast cancer cells in the lab, benefits can be observed including the reduction of those vessels "feeding" the cancer cells causing cancer cell death.

.... the natural compound exerts its anti-tumor effects in a variety of ways. Then, Hyder further tested laboratory mice with breast cancer and found that blood vessel formation and stem cell-like characteristics also were reduced in vivo, or inside the body.

From Medical Xpress: Ingredient in olive oil kills cancer cells with their own enzymes

A Rutgers nutritional scientist and two cancer biologists at New York City's Hunter College have found that an ingredient in extra-virgin olive oil kills a variety of human cancer cells without harming healthy cells. The ingredient is oleocanthal, a compound that ruptures a part of the cancerous cell, releasing enzymes that cause cell death.

Paul Breslin, professor of nutritional sciences in the School of Environmental and Biological Sciences, and David Foster and Onica LeGendre of Hunter College, report that oleocanthal kills cancerous cells in the laboratory by rupturing vesicles that store the cell's waste....Scientists knew that oleocanthal killed some cancer cells, but no one really understood how this occurred. Breslin believed that oleocanthal might be targeting a key protein in cancer cells that triggers a programmed cell death, known as apoptosis....  

After applying oleocanthal to the cancer cells, Foster and LeGendre discovered that the cancer cells were dying very quickly – within 30 minutes to an hour....LeGendre, a chemist, provided the answer: The cancer cells were being killed by their own enzymes. The oleocanthal was puncturing the vesicles inside the cancer cells that store the cell's waste – the cell's "dumpster," as Breslin called it, or "recycling center," as Foster refers to it. These vesicles, known as lysosomes are larger in cancer cells than in healthy cells, and they contain a lot of waste. But oleocanthal didn't harm healthy cells, the researchers found. It merely stopped their life cycles temporarily – "put them to sleep," Breslin said. After a day, the healthy cells resumed their cycles.  

Image result for Mediterranean dietMore support for health benefits of a Mediterranean diet. Results of a  study comparing brain health in groups of older people (in their 60s and 70s) suggest that a Mediterranean diet supplemented with olive oil or nuts may counter-act age-related cognitive decline (overall their cognitive test scores held steady). But the group assigned to the low-fat diet (the control group) worsened on cognitive tests. The Mediterranean diet emphasizes eating vegetables, fruits, legumes (beans), nuts, whole grains, seeds, olive oil, fish, moderate consumption of dairy products (mostly as cheese and yogurt), moderate wine consumption (optional), and low consumption of meat and meat products.From the Wall Street Journal:

Mediterranean Diet Boosts Brain Power, Clinical Study Finds

The Mediterranean diet, supplemented with a handful of nuts or a few tablespoons of olive oil a day, can counteract the effects of aging on the brain’s ability to function, a new clinical study suggests.

The study, published online Monday in JAMA Internal Medicine, was unusual in that it employed rigorous scientific practices to test the effect of the diet on health....Data gathered from previous observational studies suggested that adhering to a Mediterranean-type diet related to better cognitive function and a reduced risk of dementia, but observational studies have limitations, he said.

The Mediterranean diet, which has also shown benefits in cardiovascular health, emphasizes vegetables and fruits, unrefined grains and beans. It also includes fish and wine and minimal consumption of meat and full-fat dairy products.

The study involved 447 cognitively healthy participants, 55 to 80 years of age, who were divided into three groups. Two groups followed the Mediterranean diet and added either 30 grams of mixed nuts (walnuts, hazelnuts and almonds) a day, or five tablespoons of extra virgin olive oil a day. The third group, acting as a control, was advised to follow a low-fat diet. The subjects were followed for a median of just over four years.

The results showed that, compared with the control group, memory function remained stronger in the Mediterranean diet plus nuts group, while frontal (attention and executive function) and global cognition benefited in the Mediterranean diet plus olive oil group.

The diminished decline in cognitive function likely stems from the abundance of antioxidants and anti-inflammatory agents found in the supplemental foods, Dr. Ros said. Olive oil and nuts are rich in phenolic compounds that might counteract oxidative processes in the brain, leading to neurodegeneration, the study said. “If you can delay your age-related cognitive decline, you can process tasks with higher speed,” said Dr. Ros.

The research was a substudy of a larger investigation, designed by Dr. Ros, that found the Mediterranean diet, supplemented with additional olive oil or nuts, reduced the incidence of major cardiovascular events among people at high cardiovascular risk. That study, which involved nearly 7,500 participants and known by the acronym Predimed, was published in 2013.